Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery

Gynecologic Oncology

Volumn 133, Issue 1, 2014, Pages 78-82

  Argenta, Peter ^a   Svendsen, Charles ^b   Elishaev, Esther ^c   Gloyeske, Nika ^c   Geller, Melissa A ^a   Edwards, Robert P ^c   Linkov, Faina ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Park Nicollet Foundation   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Bariatric surgery; Endometrial cancer; Endometrial hyperplasia; Estrogen receptor (ER); Obesity; Progesterone receptor (PR)

Indexed keywords

ANDROGEN RECEPTOR; ANTIESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; KI 67 ANTIGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BARIATRIC SURGERY; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIDDLE AGED; MORBID OBESITY; PATHOLOGIST; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; WEIGHT REDUCTION; YOUNG ADULT;

BARIATRIC SURGERY; ENDOMETRIAL CANCER; ENDOMETRIAL HYPERPLASIA; ESTROGEN RECEPTOR (ER); OBESITY; PROGESTERONE RECEPTOR (PR);

ADULT; ASYMPTOMATIC DISEASES; BARIATRIC SURGERY; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; OBESITY, MORBID; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 84897032606     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.12.005     Document Type: Article

References (21)

1. F. Linkov, E. Edwards, J. Balk, Stadterman B. Yurkovetsky, A. Lokshin, and E. Taioli Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors Eur J Cancer 44 2008 1632 1644
2. Disaia, and Creasman Clinical gynecologic oncology 5th ed. 1997 Mosby Year Inc. 135
3. E. Weiderpass, J.A. Baron, H.O. Adami, C. Magnusson, A. Lindgren, and R. Bergstrom et al. Low potency oestrogen and risk of endometrial cancer: a case control study Lancet 353 9167 1999 1824 1828
4. K. Basen-Engquist, and M. Chang Obesity and cancer risk: recent review and evidence Curr Oncol Rep 13 1 2011 71 76
5. S.J. Lewis, A. Murad, L. Chen, G. Davey Smith, J. Donovan, and T. Palmer et al. Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk PLoS One 5 10 2010 e13485
6. A.G. Renehan, I. Soerjomataram, and M.F. Leitzmann Interpreting the epidemiological evidence linking obesity and cancer: a framework for population-attributable risk estimations in Europe Eur J Cancer 46 14 2010 2581 2589
7. Y. Ma, Y. Yang, F. Wang, P. Zhang, C. Shi, and Y. Zou et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies PLoS One 8 1 2013 e53916
8. L.J. Havrilesky, G.L. Maxwell, and E.R. Myers Cost-effectiveness of annual screening strategies for endometrial cancer Am J Obstet Gynecol 200 2009 640.e1 640.e8
9. P. Argenta, M. Kassing, A. Truskinovsky, and C. Svendsen Bariatric surgery and endometrial pathology in asymptomatic morbidly obese women: a prospective, pilot study BJOG 120 7 Jun 2013 795 800
10. R.J. Kurman, P.F. Kaminski, and H.J. Norris The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients Cancer 56 1985 403 412
11. C.L. Trimble, M. Method, M. Leitao, K. Lu, O. Ioffe, and M. Hampton et al. Society of Gynecologic Oncology Clinical Practice Committee Obstet Gynecol 120 5 Nov 2012 1160 1175
12. D. Bender, T. Bruekers, and K.K. Leslie Hormones and receptors in endometrial cancer Proc Obstet Gynecol 2 2011 1 25
13. R.A. Smith, V. Cokkinides, and O.W. Brawley Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J Clin 59 2009 27 41
14. A.N. Fader, L. Nieves Arriba, H.E. Frasure, and V.E. von Gruenigen Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship Gynecol Oncol 114 1 2009 121 127
15. A.S. Viola, D. Gouveia, L. Andrade, J.M. Aldrighi, C.F.M. Viola, and L. Bahamondes Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women Aust N Z J Obstet Gynaecol 48 2 2008 207 213
16. I. Mylonas, U. Jeschke, N. Shabani, C. Kuhn, S. Kriegel, and M.S. Kupka et al. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha, estrogen receptor beta, and progesterone receptor Anticancer Res 25 2005 1679 1686
17. J.C. Felix, and S. Farahmand Endometrial glandular proliferation and estrogen receptor content during the normal menstrual cycle Contraception 55 1997 19 22
18. B. Schirmer Morbid obesity C.M. Townsend, R.D. Beauchamp, B.M. Evers, K.L. Mattox, Sabiston textbook of surgery 17th ed. 2004 Elsevier Philadelphia, PA 357 399
19. R.A. Perugini, and S. Malkani Remission of type 2 diabetes mellitus following bariatric surgery: review of mechanisms and presentation of the concept of 'reversibility' Curr Opin Endocrinol Diabetes Obes 18 2 2011 119 128
20. B. Woelnerhanssen, R. Peterli, R.E. Steinert, T. Peters, Y. Borbély, and C. Beglinger Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy - a prospective randomized trial Surg Obes Relat Dis 7 5 2011 561 568
21. G.G. Gosman, H.I. Katcher, and R.S. Legro Obesity and the role of gut and adipose hormones in female reproduction Hum Reprod Update 12 5 2006 585 601